cn 100 has been researched along with Erythema in 2 studies
CN 100: structure given in first source
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsurumi, K | 2 |
| Kyuki, K | 2 |
| Niwa, M | 1 |
| Mibu, H | 1 |
| Fujimura, H | 2 |
| Yanagihara, M | 1 |
| Hasegawa, J | 1 |
2 other studies available for cn 100 and Erythema
| Article | Year |
|---|---|
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Benzopyrans; Benzothiepins; | 1986 |
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 5th communication: antiplatelet effect of the drug and antiinflammatory effect of its main metabolite.
Topics: Animals; Anti-Inflammatory Agents; Benzothiepins; Biotransformation; Blood Platelets; Diarrhea; Edem | 1986 |